Joseph C. Scodari, Director at Acurx Pharmaceuticals, Inc. (ACXP), bought 24,631 shares at $1.02 ($25K) on 2025-01-06, disclosed to the SEC on 2025-01-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| OPTN | BUY | 2019-12-09 | $100K | — | Filing → |
| OPTN | BUY | 2018-12-12 | $101K | — | Filing → |
| CVD | BUY | 2011-06-27 | $46K | — | Filing → |